Pacira Pharmaceuticals, Inc
pacira.comTotal trials
102
Active
6
Phase 3
23
Total enrollment
18,813
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Zilretta | — | — | — | — | 2 | ||
| Enekinragene Inzadenovec | — | — | — | — | — | 1 | |
| EXPAREL | — | — | — | 20 | |||
| Bupivacaine | — | — | — | — | 5 | ||
| FX201 | — | — | — | — | — | 1 |
Next readouts
- 2023-11-28
- 2026-12
- 2027-01
- 2032-07
Top conditions
- Postoperative Pain14
- Pain10
- Osteoarthritis of the Knee9
- Postoperative Pain Management6
- Bunion5
- Pain Management4
- Bowel Obstruction4
- Knee Osteoarthritis3
Frequently asked questions about Pacira Pharmaceuticals, Inc
- How many clinical trials does Pacira Pharmaceuticals, Inc have on ClinicalTrials.gov?
- Pacira Pharmaceuticals, Inc is listed as the lead sponsor on 102 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Pacira Pharmaceuticals, Inc's trials are in Phase 3?
- 23 of Pacira Pharmaceuticals, Inc's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Pacira Pharmaceuticals, Inc focus on?
- Pacira Pharmaceuticals, Inc's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Pain, Osteoarthritis of the Knee, Postoperative Pain Management, Bunion.
- When are Pacira Pharmaceuticals, Inc's next clinical trial readouts?
- Pacira Pharmaceuticals, Inc has 4 upcoming primary-completion readouts tracked here; the soonest is “Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee”, expected around 2023-11-28.